Profile
AVGR ISRG BDXA BDX RMD ALC
Company Name Avinger, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company ResMed Inc. Alcon Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.52M $167.60B $55.91B $54.60B $40.88B $39.47B
Employees 0.07K 15.64K 0.00K 70.00K 9.98K 25.60K
CEO Nabeel P. Subainati CPA Gary S. Guthart - Thomas E. Polen Jr. Michael J. Farrell BE, MBA, SM David J. Endicott
Ratings
AVGR ISRG BDXA BDX RMD ALC
Quant Rating Score 2 3 5 3 4 3
Quant Rating Sell Neutral Strong Buy Neutral Buy Neutral
Trading
AVGR ISRG BDXA BDX RMD ALC
Last Close $0.474 $449.68 $59.24 $186.84 $270.14 $78.29
High 52 $1.45 $610.45 $59.24 $249.08 $293.73 $100.07
Low 52 $0.38 $441.23 $59.24 $165.15 $204.58 $77.87
Price vs. 52 Week High -67.31 % -26.34 % 0 % -24.99 % -8.03 % -21.76 %
Price vs. 52 Week Low 24.74 % 1.92 % 0 % 13.13 % 32.05 % 0.54 %
Total Return
AVGR ISRG BDXA BDX RMD ALC
1 Month Return 0 % -5.73 % 0 % -4.18 % -5.11 % -9.79 %
3 Month Return 0 % -12.2 % 0 % 8.5 % 8.34 % -9.18 %
6 Month Return 0 % -7.18 % 0 % -17.32 % 20.51 % -11.99 %
9 Month Return -24.87 % -16.66 % 0 % -17.17 % 13.26 % -6.99 %
YTD Return -42.05 % -13.85 % 0 % -17.64 % 18.12 % -7.77 %
1 Year Return -60.66 % -8.2 % 0 % -20.22 % 8.52 % -20.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVGR ISRG BDXA BDX RMD ALC
Dividend Yield Percentage (TTM) - - 2.13 % 2.18 % 0.78 % 0.42 %
Dividend Paid and Capex Coverage Ration (TTM) -171.74 % 3.4 % 1.73 % 1.73 % 4.34 % 3.26 %
Dividend Per Share (TTM) - - 4.07 % 4.16 % 2.19 % 0.33 %
Payout Ratio (TTM) -0.48 % - 73.1 % 73.1 % 22.19 % 15.71 %
Growth
AVGR ISRG BDXA BDX RMD ALC
Asset Growth -43.09 % 8.54 % 2.48 %
Gross Profit Growth -24.53 % 11.69 % 5.05 %
Revenue Growth -7.51 % 4.16 % 4.82 %
Revenue 3 Year -81.76 % 5.3 % 18.48 %
Revenue 5 Year -99.56 % 8.72 % 30.35 %
Revenue 10 Year -99.99 % 59.37 % 50.3 %
EBIT Growth -4.25 % 19.82 % 41.82 %
Net Income Growth -5.12 % 14.89 % 4.52 %
Net Income 3 Yeari Growth Per Share 80.7 % -18.63 % 168.34 %
Net Income 5 Yeari Growth Per Share 99.7 % 28.82 % 253.24 %
Net Income 10 Yeari Growth Per Share 100 % -4.02 % 239.64 %
Operating Income Growth -4.25 % 13.55 % 36 %
Operating Cash Flow Growth (CFG) 13.89 % 27.07 % 49.64 %
Operating 3 Year CFG 79.69 % -18.4 % 53.05 %
Operating 5 Year CFG 99.65 % 6.25 % 122.93 %
Operating 10 Year CFG 100 % 45.28 % 55.79 %
EPS Growth 44.27 % 18.31 % 4.04 %
EPS Diluted Growth 44.27 % 18.62 % 4.59 %
Book Value Per Share -179.29 % -0.85 % 4.21 %
Share Holder 3 Year Equity Growth Per Share -109.9 % 9.16 % 10.93 %
Share Holder 5 Year Equity Growth Per Share -100.3 % 14.4 % 10.26 %
Share Holder 10 Year Equity Growth Per Share 100 % 241.78 % -9.87 %
Dividend Per Share Growth -100 % -2.44 % 11.75 %
Dividend 3 Year Growth Per Share -100 % 4.79 % 138.09 %
Dividend 5 Year Growth Per Share -100 % 4.14 % -
Dividend 10 Year Growth Per Share - 74.3 % -
Debt Growth -5.89 % 31.74 % 0.02 %
Free Cash Flow Growth 14.1 % 45.25 % 162.01 %
Updated On 31 Dec 2023 30 Sep 2024 31 Dec 2024
Profitability
AVGR ISRG BDXA BDX RMD ALC
Gross Profit Margin TTM 21.42 % 66.65 % 45.08 % 45.08 % 59.36 % 55.13 %
Return on Assets TTM -99.88 % 12.93 % 2.93 % 2.93 % 17.14 % 3.42 %
Return on Equity TTM -538.09 % 15.57 % 6.31 % 6.31 % 25.51 % 4.93 %
Return on Capital Employed TTM -314.42 % 14.26 % 5.78 % 5.78 % 23.58 % 4.98 %
Net Income Per EBT TTM 100 % 87.46 % 83.91 % 83.91 % 83.5 % 85.57 %
EBT Per Ebit TTM 105.43 % 113.2 % 70.86 % 70.86 % 99.42 % 86.96 %
EBIT Per Revenue TTM -240.57 % 28.8 % 12.63 % 12.63 % 32.79 % 14.38 %
Cash Flow To Debt Ratio TTM -199.52 % - 16.82 % 16.82 % 198.52 % 39.27 %
Receivables Turnover TTM 6.11 6.56 7.27 7.27 5.48 4.98
Payables Turnover TTM 4.57 11.43 - 1.85 7.52 5.03
Inventory Turnover TTM 1.12 1.83 2.97 2.97 2.25 1.88
Fixed Asset Turnover TTM 282.94 % 183.44 % 313.67 % 313.67 % 716.47 % 197.54 %
Asset Turnover TTM 39.38 % 45.35 % 38.95 % 38.95 % 62.96 % 31.94 %
Operating Cash Flow Per Share TTM -5.02 7.88 11.3 11.3 11.96 4.16
Free Cash Flow Per Share TTM -5.02 5.56 8.85 8.85 11.32 3.23
Cash Per Share TTM 265.33 % 1485.77 % 262.85 % 262.85 % 834.65 % 284.33 %
Operating Cash Flow Sales Ratio TTM -208.42 % 30.9 % 15.22 % 15.22 % 34.04 % 20.57 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 70.57 % 78.37 % 78.37 % 94.7 % 77.51 %
Cash Flow Coverage Ratios TTM -199.52 % - 16.82 % 16.82 % 198.52 % 39.27 %
Price To Free Cash Flows Ratio TTM -0.14 84.04 21.5 21.41 24.64 24.7
Price To Operating Cash Flows Ratio TTM -0.09 59.31 16.93 16.86 23.35 19.17
Price Cash Flow Ratio TTM -0.09 59.31 16.93 16.86 23.35 19.17
Income Statement (TTM)
AVGR ISRG BDXA BDX RMD ALC
Revenue $0.01B $8.35B $20.18B $20.18B $5.15B $9.91B
Gross Profit $0B $5.63B $9.13B $9.13B $3.05B $5.51B
Gross Profit Ratio 26.18% 67.46% 45.22% 45.22% 59.36% 55.61%
EBITDA $-0.02B $2.81B $4.82B $4.82B $1.91B $2.68B
Net Income $-0.02B $2.32B $1.71B $1.71B $1.4B $1.02B
EPS Diluted -23.31 6.42 5.86 5.86 9.51 2.05
Balance Sheet (MRQ)
AVGR ISRG BDXA BDX RMD ALC
Long Term Debt $0B $0.11B $18.61B $18.61B $0.81B $4.97B
Total Liabilities $0.02B $2.31B $31.4B $31.4B $2.21B $8.79B
Total Equity $-0.01B $16.53B $25.89B $25.89B $5.97B $21.55B
Total Investments $0B $7.05B $0.45B $0.45B $0.1B $0.91B
Total Debt $0.02B $0.15B $20.92B $20.92B $0.88B $5.14B
Total Assets $0.01B $18.84B $57.29B $57.29B $8.17B $30.35B
Cash Flow Statement (TTM)
AVGR ISRG BDXA BDX RMD ALC
Net Income $-0.02B $2.34B $1.71B $1.71B $1.4B $1.02B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.08B $-0.05B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.31B $-0.13B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $1.75B $2.08B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.09B $-0.67B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.29
ANGO AngioDynamics, Inc. 10.65
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 135.23
ATRC AtriCure, Inc. 35.07
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AZTA Azenta, Inc. 29.66
BAX Baxter International Inc. 23.99
BDX Becton, Dickinson and Company 186.84
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.19
BLFS BioLife Solutions, Inc. 25.51
COO The Cooper Companies, Inc. 66.68
DXR Daxor Corporation 11.66
EKSO Ekso Bionics Holdings, Inc. 3.83
FEMY Femasys Inc. 0.3921
GCTK GlucoTrack, Inc. 10.59
ETFs With Exposure to AVGR
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00001 208.84
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00001 158.47
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00001 158.48
VEMPX Vanguard Extended Market Index InstlPlus 0.00001 391.07
Unlock